Cantargia competitive analysis

Latest publications and patents of Cantargia New

Explore the latest publications and patents granted to Cantargia, showcasing their recent innovations and technological advancements.

Last updated on: Sep 27, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Cantargia

Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses ThereofPatent Maintained As Amended
Dec 26, 2018Anti-Il1Rap Antibodies And Their Use For Treating HumanOpposition Rejected

Explore Cantargia's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 2, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 7, 2024Anti Human Interleukin-1 Receptor Accessory Protein (Il1Rap) Antibodies And Uses Thereof3
Dec 26, 2018Anti-Il1Rap Antibodies And Their Use For Treating Human1

Latest PTAB cases involving Cantargia

Discover the latest PTAB cases involving Cantargia, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Cantargia with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
CANTARGIA - 4 - - Non-Active
BLUEFIN BIOMEDICINE1 - - - Highly Aggressive
ICHNOS SCIENCES1 - - - Highly Aggressive
MAB DISCOVERY1 - - - Highly Aggressive